A new generation of oral weight loss medications could transform the fight against obesity and diabetes in low- and ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Shortages of pharmaceutical products have been with us for many years. The earliest example of which I am aware dates back to 1942. Currently over 100 products are in shortage, including hormone ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

"It's an oral tablet, which is a much easier ... on orforglipron as rival Rybelsus (semaglutide) is as effective to control diabetes and obesity. Novo Nordisk's Rybelsus is approved for treating ...

Union Minister for Railways and Electronics & IT, Mr. Ashwini Vaishnaw, unveiled a near-indestructible Made in India tablet. He shared his demo of the tablet from the manufacturing unit of VVDN ...

This reflects India's growing push for high-quality electronics under the 'Make in India' initiative. Union Railways and Electronics and IT Minister, Ashwini Vaishnaw, on Friday took to social ...

Union Minister Ashwini Vaishnaw recently launched a new "Made in India" tablet during the inauguration of VVDN Technologies' Surface Mount Technology (SMT) line in Manesar. To show its durability, ...

A peep at the Google Trends in India during the pandemic years shows how Dolo became synonymous with Covid-19 treatment. Querries such as: “what happens if i take 2 dolo 650 tablet", “what happens if ...

His arrest was a win for India, long hobbled in efforts to extradite its citizens. By John Yoon and Alex Travelli Alex Travelli reported from New Delhi. The F.B.I. said on Thursday that it had ...

Forms may also be drugs at some concentration in solid or liquid mixtures; 503A hospital and community pharmacies are more likely to use drug mixtures (e.g., commercial sterile IV additives and ...

This came as Novo Nordisk India sought approval for Semaglutide tablets of 1.5 mg, 4 mg, and 9 mg of a new formulation based on the BE studies conducted in the USA and Canada. In light of earlier SEC ...